S. Ignatenko
发表
A. Camez,
A. Othman,
Yinuo Pang,
2018,
Clinical Pharmacokinetics.
C. Basson,
D. Fuhrer,
A. Dokras,
2021,
Diabetes, obesity & metabolism.
V. Regitz-Zagrosek,
R. Hetzer,
M. Loebe,
2004
.
V. Regitz-Zagrosek,
R. Hetzer,
M. Loebe,
2004
.
Min Seon Kim,
M. Ruchała,
M. Bolanowski,
2018,
European journal of endocrinology.
V. Regitz-Zagrosek,
R. Hetzer,
M. Loebe,
2003,
The Annals of thoracic surgery.
O. Heudi,
H. Tillmann,
A. Drollmann,
2020,
Pulmonary pharmacology & therapeutics.
K. Grebe,
S. Wong,
R. Fleischmann,
2018,
Lupus.
H. Volk,
A. Tissot,
G. Jennings,
2008,
The Lancet.
C. Bachert,
N. Krug,
J. Hohlfeld,
2015,
The New England journal of medicine.
Safety, PK, and PD of recombinant anti-interleukin-21 monoclonal antibody in a first-in-human trial.
U. Mouritzen,
S. Ignatenko,
B. Skrumsager,
2016,
International journal of clinical pharmacology and therapeutics.
C. Bachert,
N. Krug,
J. Hohlfeld,
2015,
The New England journal of medicine.